DURECT CORP - FORM 10-K - March 1, 2016

www.getfilings.com/sec-filings/160301/DURECT-CORP_10-K/

20 hours ago - SECURITIES AND EXCHANGE COMMISSION .... The more advanced programs are in the field of pain management and we believe that each of ... The lead compound from this program (DUR-928) is an endogenous, orally bioavailable ...... Our transdermal bupivacaine patch (ELADUR) under development is intended to ..